Study Looks at CDS Effectiveness | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Study Looks at CDS Effectiveness

December 5, 2011
by root
| Reprints


A new report from Orem, Utah-based KLAS, Clinical Decision Support 2011: Understanding the Impact, asked 344 providers to rate their Clinical Decision Support (CDS) tools’ performance to better understand the influence of these new CDS tools on patient care.




KLAS measured levels of impact by asking providers to rate their influence on clinical decisions and standardizing care. Provider response was passionate and, in some cases, polarized. The study found most tools did well in one of these main arenas, but rarely in both.




Measured CDS areas included care plans, diagnostic tools, disease reference tools, drug databases, drug reference tools, order sets, and surveillance tools. The study examined vendors such as Cerner, EBSCO, Elsevier, First DataBank, Isabel, Logical Images, Thomson Reuters, Wolters Kluwer, and Zynx.




Respondents say poor integration with clinical workflow is the Achilles heel hindering CDS success. Additionally, many reported issues with alert fatigue—politely describing it as an “overly sensitive mess.”




Though every CDS segment had key struggles, KLAS noted that providers are optimistic about the future as CDS tools increase in workflow integration, usability, and adoption.




Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

KLAS Research: Small Hospitals’ Buying Decisions Impacting EMR Market Share

A new KLAS Research report tracks shifts in electronic medical record (EMR) vendor market share among acute care hospitals, and finds that smaller hospitals are seeking technology solutions that meet their needs and limited budgets, and these contracts are making a mark on the EMR market.

Survey: Majority of Providers Predict Success for New Generic Drug Company, Project Rx

Back in January, four health systems, in consultation with the VA, announced a collaboration to develop a new, not-for-profit generic drug company. A survey has found that 90 percent of providers say they would become customers of the new venture.

Personalized Medicine Awareness Low Among U.S. Adults, Survey Finds

Genetics and personalized medicine are not top of mind for the general public in the U.S., according to a recent survey from GenomeWeb and the Personalized Medicine Coalition.

Industry Organizations Praise Senate Passage of VA Mission Act

The U.S. Senate on Wednesday passed, by a vote of 92-5, a major Veterans Affairs (VA) reform bill that includes health IT-related provisions to improve health data exchange between VA healthcare providers and community care providers.

NIH Issues Funding Announcement for All of Us Genomic Research Program

The National Institutes of Health’s (NIH) “All of Us” Research Program has issued a funding announcement for genome centers to generate genotype and whole genome sequence data from participants’ biosamples.

MGMA: Physician Compensation Data Illustrates Nationwide PCP Shortage

Primary care physicians’ compensation rose by more than 10 percent over the past five years, representing an increase which is nearly double that of specialty physicians’ compensation over the same period, according to the Medical Group Management Association (MGMA).